Digitalization of toxicology: improving preclinical to clinical translation.

Though the portfolio of medicines that are extending and improving the lives of patients continues to grow, drug discovery and development remains a challenging business on its best day. Safety liabilities are a significant contributor to development attrition where the costliest liabilities to both drug developers and patients emerge in late development or post-marketing. Animal studies are an important and influential contributor to the current drug discovery and development paradigm intending to provide evidence that a novel drug candidate can be used safely and effectively in human volunteers and patients.

Development of the Digital Arthritis Index, a Novel Metric to Measure Disease Parameters in a Rat Model of Rheumatoid Arthritis.

Despite a broad spectrum of anti-arthritic drugs currently on the market, there is a constant demand to develop improved therapeutic agents. Efficient compound screening and rapid evaluation of treatment efficacy in animal models of rheumatoid arthritis (RA) can accelerate the development of clinical candidates. Compound screening by evaluation of disease phenotypes in animal models facilitates preclinical research by enhancing understanding of human pathophysiology; however, there is still a continuous need to improve methods for evaluating disease.

An ingestible sensor for measuring medication adherence.

In this paper, we describe the design and performance of the first integrated-circuit microsensor developed for daily ingestion by patients. The ingestible sensor is a device that allows patients, families, and physicians to measure medication ingestion and adherence patterns in real time, relate pharmaceutical compliance to important physiologic metrics, and take appropriate action in response to a patient's adherence pattern and specific health metrics. The design and theory of operation of the device are presented, along with key in-vitro and in-vivo performance results.

Early clinical experience with networked system for promoting patient self-management.

Objective: To gain early experience with a networked system designed to assess a patient's adherence to oral medication and physiologic metrics in an ambulatory, at-home setting.

Study Design: Prospective, observational studies.

Materials And Methods: This networked system for patient self-management consists of ingestible markers and a wearable, personal monitor.

Microholographic multilayer optical disk data storage.

Micrometer-sized reflection holograms can be written into a rapidly rotating homogeneous photopolymer disk at the focus of a high-numerical-aperture beam and its retroreflection to implement high-capacity multilayer digital data storage. This retroreflection is generated by an optical system with positive unity magnification to ensure passive alignment of the counterpropagating beam. Analysis reveals that the storage capacity and transfer rate of this bit-based holographic storage system compare favorably with traditional page-based systems but at a fraction of the system complexity and cost.